3rd June 2025

NHS Waiting List Cover: An Overlooked But Vital Protection Benefit

There’s a natural tendency for protection advisers to focus on critical illness conditions and the intricacies of claim wordings. After all, the likelihood of a successful claim often defines the perceived value of an insurer’s offering.

However, in recent years, a wider range of ancillary benefits has emerged as key differentiators - from birth defect cover to enhanced health services like annual health MOTs. Among these, one benefit has grown increasingly relevant and vital: NHS Waiting List Cover.

This feature rarely takes centre stage in protection conversations. Yet, given the ongoing crisis in the National Health Service, it’s now one of the most important aspects of modern protection plans.

The Scale of the NHS Backlog 

The numbers are stark. As of February 2025, NHS England reported a record waiting list of 7.43 million people, up from 4.5 million just before the first Covid-19 lockdown. In January 2025 alone, over 3 million patients had been waiting more than 18 weeks for hospital treatment - and nearly 200,000 had been waiting over a year.

Cardiology departments in major London hospitals currently show average wait times of 16 weeks following referral. In Scotland, the government’s 18-week treatment target was met in only 66.4% of cases during 2023. Meanwhile, Wales reported an average wait of 20.4 weeks at the end of the same year.

These delays have real-life consequences - especially for those facing time-sensitive conditions. And this is where waiting list cover can make a meaningful difference.

A Growing but Uneven Offering

Originally, only major organ transplant claims qualified for NHS waiting list benefits. Since 2010, however, this area has expanded significantly. The Vitality SIC3 plan, for example, now includes 20 conditions eligible for waiting list payouts. Guardian and Royal London follow closely, each covering 14 conditions. 

Yet coverage varies greatly across the market. Many plans, especially those sold through direct-to-consumer (D2C) channels, include few or no waiting list conditions. The table below highlights this disparity:

As expected, it’s the higher-quality, adviser-distributed plans that lead in this area - often for only a modest premium increase.

The Value of Early Payouts

Many of the conditions covered are cardiac-related, which is especially relevant considering the NHS backlog in cardiology. Guardian, for instance, includes nine separate heart conditions under its waiting list feature. These policies allow clients to receive early payouts if they’re placed on an NHS waiting list for one of the specified conditions — giving them the option to fund faster private treatment.

However, this benefit is only as effective as the insurer’s claims process. Advisers have noted a general slowdown in claims handling across the market. When the benefit is time-sensitive, potentially life-saving, a swift payout can be critical. Insurers that can process and pay waiting list claims quickly will be delivering far more than just financial support - they may be materially improving outcomes.

A Benefit Whose Time Has Come

Waiting list cover was once a niche addition. Today, in the face of prolonged NHS delays and rising public frustration, it’s a core differentiator that advisers should factor into every protection recommendation.

In an environment where clients cannot afford to wait, protection that pays early could be the difference between enduring uncertainty and securing timely treatment. It’s time advisers gave this benefit the attention it now deserves.

Alan Lakey, CI Expert

Protection